TRU - Truscreen

[HITMAN]

Happy holding, yeh neigh on .30 two years ago down to .05 now, great investment , once the current capital is gone whats the next one to be at .02 or lower to get it across the line, good luck !

5 years ago it touch 30c. But good to see your support with following for such a long time. I agree, there is a huge risk, financials aren’t exactly coloured in gold. I like the product, I like what it can do. Friends I have who have suffered cancer hated the PAP smear. The process, the wait.

I can see positive, which is why I’ve increased my holding. I can see the announcement in May with growth now happening again in China during COVID-19, 58 hospitals. I then notice the latest results saying 66 hospitals one month later.

TruScreen has a history of under performing and under delivering, I like Tony Ho’s financial investment in the company, I’m a fan of the new CEO. I’m glad Rob Hunter has gone, let’s see the new team get some results. 5 million to play with, interesting next 24 months.

[HITMAN]

Quiet little update from this BS company...

http://nzx-prod-s7fsd7f98s.s3-websit...120/326257.pdf

disc: happy holding.

[Not The Chosen One]

Quiet little update from this BS company...

http://nzx-prod-s7fsd7f98s.s3-websit...120/326257.pdf

disc: happy holding.

Has been quietly creeping upwards the last few weeks with a decent jump today. I can see a lot of positives but history shows it doesn't equate to much until we see the numbers actually come through.

Also happy holding

[whatsup]

Has been quietly creeping upwards the last few weeks with a decent jump today. I can see a lot of positives but history shows it doesn't equate to much until we see the numbers actually come through.

Also happy holding

BGI sister company ?

[Not The Chosen One]

BGI sister company ?

More like 2nd cousins. Close but not that close.

[Stock888]

Going up like PEB?

[Cadalac123]

Punters hoping a recurrence of the PEB story

[Stock888]

PEB gave me great returns.

[Stock888]

Go higher!

[Not The Chosen One]

Slowly but surely. Emphasis is on the word slowly, here

TruScreen strengthens its market presence in central and eastern Europe

As part of the rationalisation of its distributors network, Truscreen Limited
(NZX: TRU) ("the Company") is pleased to announce that it has appointed
prominent medical device distributor Aspironix, s.r.o (Aspironix) as its
exclusive distributor for Czech Republic, Slovakia, and Poland.

The territories of Czech Republic, Slovakia, and Poland, have a combined
cervical cancer addressable screening population of over 17.91 million women,
presenting a significant market opportunity for the Company.

Asprionix is a well-established specialised medical device distributor based
in Prague, with a rapidly growing turnover and increasing presence in central
and eastern Europe.

Together with Aspironix, the Company will develop a comprehensive market
access plan and have begun preliminary Key Opinion Leaders (KOL) engagement
for the region.

Truscreen CEO, Victoria Potarina, said "The distribution agreement with
Aspironix will enable us to significantly expand our distribution
capabilities in central and eastern Europe, bringing Truscreen's latest
real-time cervical cancer screening technology to the women of Czech
Republic, Slovakia and Poland.

The rationalisation of our distributor portfolio will see established and
committed medical device distributors, like Aspironix partnering with
Truscreen to bring our Truscreen cervical cancer screening technology to the
millions of women who are currently not covered by effective cervical cancer
screening."